Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Looking for Oncology Payoff, Astellas Makes Hostile Bid for Tarceva Maker OSI

Mar 01 2010

• By Alex Lash

Related Content

Medivation Gets $110M Upfront From Astellas In Prostate Cancer Collaboration

Oct 27 2009

Astellas Advances Antibody R&amp;D Agenda With Agensys Purchase Worth Up To $537 Million

Nov 27 2007

Takeda's Global Ambition

Jun 01 2008

Thrust &amp; Parry: CVT And Gilead Look To Lock Out Astellas With Planned Merger

Mar 12 2009

Tarceva Gets Thumbs Down For NSCLC Maintenance As Cmte. Seeks Better Subgroup Analyses

Dec 16 2009

Astellas Signs Strategic Oncology Partnership With Ambit After Medivation Success

Dec 18 2009

Astellas Turns Up Heat On Bid To Acquire CV Therapeutics

Feb 27 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window